Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's Sarcoma

This publication has 35 references indexed in Scilit:

• Reduced incidence of kaposi's sarcoma and of systemic non‐hodgkin's lymphoma in HIV‐infected individuals treated with highly active antiretroviral therapy
  International Journal of Cancer, 2002
• Effect of highly active antiretroviral therapy on survival among HIV‐infected men with Kaposi sarcoma or non‐Hodgkin lymphoma
  International Journal of Cancer, 2002
• Effect of Highly Active Antiretroviral Therapy on Survival in Patients With AIDS-Associated Pulmonary Kaposi’s Sarcoma Treated With Chemotherapy
  Journal of Clinical Oncology, 2001
• The Changing Pattern of AIDS-defining Illnesses with the Introduction of Highly Active Antiretroviral Therapy (HAART)in a London Clinic
  Journal of Infection, 2001
• Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected Adults
  JNCI Journal of the National Cancer Institute, 2000
• Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcoma
  AIDS, 1999
• Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study
  BMJ, 1999
• Kaposi's sarcoma regression following treatment with a triple antiretroviral regimen containing nevirapine
  International Journal of STD & AIDS, 1999
• Continued Therapy with HIV-1 Protease Inhibitors, Despite Previous Hypersensitivity Reactions, Through Coadministration of Prednisone
  Scandinavian Journal of Infectious Diseases, 1998